PCP-based mice models of schizophrenia: differential behavioral, neurochemical and cellular effects of acute and subchronic treatments

Phencyclidine Inhibits the Activity of Thalamic Reticular Gamma-Aminobutyric Acidergic Neurons in Rat Brain

(2014) Eva Troyano-Rodriguez et al.   BIOLOGICAL PSYCHIATRY

Re-evaluating the PCP challenge as a pre-clinical model of impaired cognitive flexibility in schizophrenia

(2014) Laetitia Fellini et al.   EUROPEAN NEUROPSYCHOPHARMACOLOGY

Differential effects of NMDA receptor antagonists at lower and higher doses on basal gamma band oscillation power in rat cortical electroencephalograms

(2014) Tetsuaki Hiyoshi et al.   NEUROPHARMACOLOGY

Acute and chronic effects of NMDA receptor antagonists in rodents, relevance to negative symptoms of schizophrenia: A translational link to humans

(2013) Joanna C. Neill et al.   EUROPEAN NEUROPSYCHOPHARMACOLOGY

Reviewing the ketamine model for schizophrenia

(2013) Joel Frohlich et al.   JOURNAL OF PSYCHOPHARMACOLOGY

NMDA receptor subunit diversity: impact on receptor properties, synaptic plasticity and disease

(2013) Pierre Paoletti et al.   NATURE REVIEWS NEUROSCIENCE

Animal models of neuropsychiatry revisited: A personal tribute to Teitelbaum

(2012) T.W. Robbins   BEHAVIOURAL BRAIN RESEARCH

Glutamatergic Animal Models of Schizophrenia

(2012) Corina Bondi et al.   CURRENT PHARMACEUTICAL DESIGN

Role of the anterior thalamic nucleus in the motor hyperactivity induced by systemic MK-801 administration in rats

(2012) Ximena López Hill et al.   NEUROPHARMACOLOGY

Activation of Thalamocortical Networks by the N-methyl-D-aspartate Receptor Antagonist Phencyclidine: Reversal by Clozapine

(2011) Noemí Santana et al.   BIOLOGICAL PSYCHIATRY

Animal models of schizophrenia

(2011) CA Jones et al.   BRITISH JOURNAL OF PHARMACOLOGY

Mouse strain differences in phencyclidine-induced behavioural changes

(2011) Akihiro Mouri et al.   INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY

From Revolution to Evolution: The Glutamate Hypothesis of Schizophrenia and its Implication for Treatment

(2011) Bita Moghaddam et al.   NEUROPSYCHOPHARMACOLOGY

Effects of asenapine, olanzapine, and risperidone on psychotomimetic-induced reversal-learning deficits in the rat

(2010) Samantha L. McLean et al.   BEHAVIOURAL BRAIN RESEARCH

Mouse behavioral endophenotypes for schizophrenia

(2010) Laura C. Amann et al.   BRAIN RESEARCH BULLETIN

N-methyl-d-aspartate (NMDA) receptor dysfunction or dysregulation: The final common pathway on the road to schizophrenia?

(2010) Joshua T. Kantrowitz et al.   BRAIN RESEARCH BULLETIN

Activation of α7 nicotinic receptors improves phencyclidine-induced deficits in cognitive tasks in rats: Implications for therapy of cognitive dysfunction in schizophrenia

(2010) Samantha L. McLean et al.   EUROPEAN NEUROPSYCHOPHARMACOLOGY

Animal models of cognitive dysfunction and negative symptoms of schizophrenia: Focus on NMDA receptor antagonism

(2010) Joanna C. Neill et al.   PHARMACOLOGY & THERAPEUTICS

A within-subject cognitive battery in the rat: differential effects of NMDA receptor antagonists

(2010) Sophie Dix et al.   PSYCHOPHARMACOLOGY

Dissociation of acute and chronic intermittent phencyclidine-induced performance deficits in the 5-choice serial reaction time task: influence of clozapine

(2010) David M. Thomson et al.   PSYCHOPHARMACOLOGY

Evaluation of NMDA receptor models of schizophrenia: Divergences in the behavioral effects of sub-chronic PCP and MK-801

(2009) Alexandre Seillier et al.   BEHAVIOURAL BRAIN RESEARCH

Effects of quetiapine on phencyclidine-induced cognitive deficits in mice: A possible role of α1-adrenoceptors

(2009) Yuko Tanibuchi et al.   EUROPEAN NEUROPSYCHOPHARMACOLOGY

Sertindole improves sub-chronic PCP-induced reversal learning and episodic memory deficits in rodents: involvement of 5-HT6 and 5-HT2A receptor mechanisms

(2009) Nagi Idris et al.   PSYCHOPHARMACOLOGY

Role of 5-HT receptor mechanisms in sub-chronic PCP-induced reversal learning deficits in the rat

(2009) Samantha L. McLean et al.   PSYCHOPHARMACOLOGY

Modeling the Positive Symptoms of Schizophrenia in Genetically Modified Mice: Pharmacology and Methodology Aspects

(2009) M. van den Buuse   SCHIZOPHRENIA BULLETIN

Effects of subchronic phencyclidine (PCP) treatment on social behaviors and operant discrimination and reversal learning in C57BL/6J mice

(2009) Jonathan L. Brigman   Frontiers in Behavioral Neuroscience

Striatal Dopamine and Working Memory

(2008) S. M. Landau et al.   CEREBRAL CORTEX

The absence of 5-HT1A receptors has minor effects on dopamine but not serotonin release evoked by MK-801 in mice prefrontal cortex

(2008) Anna Castañé et al.   PSYCHOPHARMACOLOGY

Subchronic and chronic PCP treatment produces temporally distinct deficits in attentional set shifting and prepulse inhibition in rats

(2008) Alice Egerton et al.   PSYCHOPHARMACOLOGY